Abstract: Low-grade sinonasal adenocarcinomas (low-grade SNACs) of the sinonasal tract comprise a poorly characterized and histologically heterogeneous group of tumors. We describe three cases of a histologically distinct variant of low-grade SNAC characterized by ETV6 gene rearrangements. The patients included 2 women (aged 32 and 88 y) and a man (aged 75 y); all were initially treated with surgery alone. Follow-up ranged from 9 to 170 months with one patient having 2 local recurrences and none experiencing distant or regional metastases. Tumors were composed of cytologically bland columnar and cuboidal eosinophilic tumor cells with basally located nuclei arranged in tubular and tubulotrabecular patterns. Immunohistochemically, CK7, DOG1, GCDFP-15, and SOX10 were positive in all cases, and vimentin was positive in 2 cases. Scattered single cells or small groups of tumor cells were S-100 positive. Only one case had weak, focal expression of GATA3, and mammaglobin was consistently negative. Two cases had ETV6-NTRK3 gene fusions, whereas ETV6 had an unknown fusion partner gene in one case. The highly similar morphology, immunohistochemical profile, and genetics of the presented cases are suggestive of a specific disease. Although translocation-associated adenocarcinomas in the sinonasal tract have previously been described exclusively as salivary-type carcinomas, we present the first type of carcinoma characterized by recurrent genetic rearrangements and distinct phenotype occurring exclusively in the sinonasal tract with no known major salivary gland counterpart. We provisionally designate this tumor ETV6-rearranged low-grade SNAC. Identification of additional cases is necessary to fully appreciate the morphologic and biological spectrum of this disease.
T he sinonasal tract gives rise to a remarkably diverse spectrum of neoplasms ranging from epithelial to mesenchymal, melanocytic, and neuroectodermal in origin. 1 Among epithelial malignancies, adenocarcinomas constitute the second largest group, which is divided into salivary type, intestinal type, and a third group without salivary or intestinal adenocarcinoma characteristics. 2 This latter group of sinonasal adenocarcinomas (SNACs) is divided into low-grade and high-grade types depending on the pattern of growth and invasion, cellular pleomorphism, and mitotic activity. [2] [3] [4] Accordingly, the prognosis is favorable for low-grade SNACs with only rare disease-related death and local recurrence in B20% of cases, whereas the prognosis is grave for high-grade SNACs with a 3-year disease-specific survival of B20%. [4] [5] [6] Although the pathogenesis of intestinal-type adenocarcinoma is known to be associated with occupational exposures, the cause of nonintestinal types is unknown. 7 Whether SNACs originate from the surface epithelium or from the submucosal seromucinous glands is a matter of debate, reflected in the numerous different designations previously assigned to this type of neoplasm. 5, [8] [9] [10] [11] [12] Low-grade SNAC occurs in a wide range of ages and sinonasal sites, with middle-aged individuals being mainly affected. Involvement of the ethmoid sinus is most frequent, followed by the nasal cavity and maxillary sinuses. 5, 12, 13 Histologically, low-grade SNACs are heterogeneous, often with tubular and papillary features arranged back-to-back with little or no intervening stroma, but cribriform and trabecular growth patterns can be found, even within the same specimen. 2 Usually lined by a single layer of uniform columnar or cuboidal tumor cells, low-grade SNAC display minimal atypia. 2 Currently, no molecular markers for the separation of low-grade from high-grade lesions have been identified. 14 Secretory carcinoma (SC), initially termed mammary analog secretory carcinoma, was described by Ska´lova´et al 15, 16 in 2010 as a salivary gland tumor entity with a distinct histology and immunohistochemical profile, characterized by S-100 and mammaglobin expression and the absence of DOG1 expression, identical to that of SC of the breast. Regardless of the site, SC is defined by rearrangement of the ETS variant 6 (ETV6) gene and, most frequently, the Neurotrophic receptor tyrosine kinase type 3 (NTRK3) gene, resulting in the ETV6-NTRK3 gene fusion. [15] [16] [17] [18] This fusion oncogene is recurrently involved in a diverse array of human malignancies. [19] [20] [21] [22] SC is most frequently found in the parotid gland and the intraoral minor salivary glands. 23 To date, only one case of SC has been described in the sinonasal tract. 24 In the head and neck, the involvement of ETV6 and NTRK3 genes has so far been regarded as characteristic for SC. 25 More recently, ETV6-rearranged carcinomas have been reported in the thyroid and skin. 26, 27 We describe a morphologically distinct subset of sinonasal low-grade SNAC characterized by ETV6 gene fusions, often involving NTRK3 as the fusion partner. We term this entity ETV6-rearranged low-grade sinonasal adenocarcinoma (ETV6-rearranged low-grade SNAC). This is the first type of carcinoma found exclusively in the sinonasal tract characterized by a recurrent fusion gene.
MATERIALS AND METHODS

Patient Material
After the identification of an index case (case 1), a total of 46 low-grade SNACs of various morphologies were retrieved from the surgical pathology archives from the institutions of the authors and were screened with ETV6 fluorescence in situ hybridization (FISH) breakapart probe. 3 To investigate the possibility of ETV6 rearrangements in lesions with some morphologic similarities with low-grade SNACs, 3 respiratory epithelial adenomatoid hamartoma (REAH), 2 low-grade nasopharyngeal papillary adenocarcinoma (NPA), and a striated duct adenoma were investigated for ETV6 rearrangement. 28 For immunohistochemical characterization, in addition to the rearranged low-grade SNACs, 5 nonrearranged low-grade SNACs, 2 low-grade NPAs, and 4 salivary gland SCs were included. The study was approved by the Regional Ethics Committee of the Capital Region of Denmark (Journal no. H-16045939) and the Data Protection Agency (Journal no. REG-94-2014).
Histochemistry and Immunohistochemistry
The formalin-fixed, paraffin-embedded (FFPE) tissue was cut into 4 mm-thick sections. The slides were stained with hematoxylin and eosin. Periodic acid-Schiff with diastase (PASD) was performed according to standard protocol. Immunohistochemistry was performed as previously described using the antibodies listed in Table 1 . 29, 30 Briefly, sections were mounted on coated slides, deparaffinized using EZ-prep, and the antigens retrieved with CC1 in Tris buffer (pH 8.5) (all Ventana Medical Systems, Tucson, AZ). The ultraView DAB Detection kit (Ventana) was used for visualization, and slides were counterstained with Mayer hematoxylin. Positive controls as suggested on datasheets were used on each slide, and the expected reaction and subcellular site were confirmed. Negative controls were used for all antibodies.
Fluorescence In Situ Hybridization
All cases were screened with FISH using an ETV6 break-apart probe (ZytoVision GmbH, Bremerhaven, Germany), and rearranged cases were further characterized using an NTRK3 break-apart probe (ZytoVision) according to the manufacturer's instructions using the HYBrite platform as previously described. 31 After hybridization, nuclei were counterstained with DAPI II (ZytoVision). One hundred nuclei were counted, and only nuclei in which the entire nuclear membrane could be visualized were scored. Break-apart signals in >10% of tumor cells was considered to represent rearrangement. 32 
Real-time Polymerase Chain Reaction and Nucleotide Sequence Analysis
Total RNA was isolated from FFPE sections using Maxwell RSC FFPE kit (Promega, Madison, WI) according to the manufacturer's instructions. RNA was converted to complementary DNA (cDNA) using the Superscript VILO cDNA synthesis kit (Thermo Fisher Scientific, Waltham, MA) and performed according to the manufacturer's instructions. RNA integrity was tested using primer pairs for the phosphoglycerate kinase gene (PGK1), as described previously. 33 The cDNA samples were then subjected to real-time polymerase chain reaction (RT-PCR) using the previously described fusion primers and PCR conditions. 21, 34 The only modification made to the primers was the addition of T3 and T7 tails to forward and reverse primers, respectively, which was later used for sequencing of the amplified products. The amplified fusion products were visualized using Qiaxcel (Qiagen GmbH, Hilden, Germany), and the 150 bp amplicons were subsequently sequenced using BigDye Terminator 3.1 Cycle Sequencing Kit, T3/T7-primers, and an ABI 3500 Dx DNA sequenator according to the manufacturer's instructions (Thermo Fisher Scientific).
RESULTS
Genetic Findings
As determined with initial screening, all cases had split signals for the ETV6 gene with FISH (Figs. 1A-C, 2A) ( Table 2) . Searching for a possible fusion partner gene, NTRK3 break-apart FISH showed split signals in cases 2, 4, and 5 but fused signals in case 3 ( Fig. 2B ). In addition to split signals, one additional signal from the centromeric probe was observed in most cells of case 1 (Fig. 2C ). All 4 positive control salivary gland SCs had split signals in the ETV6 as well as the NTRK3 genes, whereas the REAHs, striated duct adenoma, and lowgrade NPAs had fused signals for both probes (data not shown).
All 5 ETV6-rearranged cases had RNA quality sufficient for RT-PCR, and a 150 bp fragment was detected in case 1, 2, 4, and 5 but not in case 3, despite strong PGK1 PCR fragments in all 5 cases (Fig. 3A) . The 150 bp fragment was identified in all 4 control salivary gland SCs (data not shown). In the 4 ETV6-rearranged cases with detectable fragments, nucleotide sequence analysis of the amplified cDNA demonstrated fusion transcripts within the junction of exon 5 of ETV6 and exon 15 of NTRK3 in all cases (Fig. 3B) . The same fusion was found in all 4 control salivary gland SCs (data not shown).
Histology and Immunohistochemical Profile
All ETV6-rearranged tumors were wellcircumscribed but unencapsulated. The ciliated surface epithelium was unremarkable in all cases. There were 2 distinct morphologic patterns; cases 1 to 3 were tubular, composed of cylindrical tumor cells resembling those of the salivary gland striated ducts (Figs. 4A, B and Figs. 5A-C). Cases 2 and 3 had cystic areas lined by cuboidal-to-cylindrical tumor cells with occasional apocrine features (Fig. 4A, insert) . In case 2, the tubular pattern was accompanied by trabecular areas devoid of lumen formation, whereas cases 1 and 3 were exclusively tubular (Figs. 5A-C). Apical PASD-positive fine cytoplasmic granules were widespread, and moderate amounts of homogeneous PASD-positive material were present in the larger luminae (Fig. 5D ). Nuclei were basally located, compact, or vesicular with granular chromatin and single centrally located nucleoli (Figs. 5A-C). The cytoplasm was brightly eosinophilic. In case 2, discrete focal intracytoplasmic vacuolization was present (Fig. 5C ). The tumor stroma was scarce, but fine fibrovascular strands were occasionally seen between tubular formations. Mitoses were rare, and no vascular or perineural growth was observed. No areas of necrosis were found in any of the 3 cases. Cases 4 and 5 were histologically identical to salivary gland SC with admixed microcystic, papillary, and tubular areas. Abundant extracellular PASD-positive material was present in both cases (data not shown). The nonrearranged low-grade SNACs were morphologically heterogeneous, with little-to-no morphologic similarity to the rearranged cases. The immunohistochemical findings are summarized in Table 3 . All 5 ETV6-rearranged cases were intensely positive for CK7 and SOX10, while being negative for CK20, TTF-1, and CD56. Consistent with being histologically similar, cases 1 to 3 had a significant overlap in staining pattern, which was different from that of cases 4 and 5. The apical membrane in cases 1 to 3 were intensely positive for DOG1 (Fig. 6A) . Scattered single tumor cells or small clusters expressed S-100 (Fig. 6B) . In cases 2 and 3, a strong, distinctive vimentin expression was located in the basal part of the tumor cells, while GCDFP-15 was diffusely positive in the apical cytoplasm (Figs. 6C, D) . Mammaglobin was consistently negative, and GATA3 was weak and focally positive in case 2 (not shown). In contrast to these findings, among cases 4 and 5 only one case weakly and focally expressed DOG1, whereas GA-TA3, mammaglobin, and S-100 were strongly and diffusely positive.
In order to clarify whether the immunohistochemical profile of ETV6-rearranged cases could aid in their identification, 5 nonrearranged low-grade SNACs, 2 low-grade NPAs, and 4 salivary gland SCs were immunohistochemically characterized for comparison (Table 3) . In contrast to cases 1 to 3 among the ETV6-rearranged cases, the nonrearranged low-grade SNACs and low-grade NPAs were devoid of DOG1 and GCDFP-15 expression. Salivary gland SCs had similar immunohistochemical profiles to cases 4 and 5 among the ETV6-rearranged cases. Hence, on the basis of morphology and genetic findings, the 2 latter cases were categorized as regular SCs and were not studied further (Table 3) .
Clinical Characteristics and Outcome
Clinicopathologic data and outcome are presented in Table 4 . Case 1 was admitted for transsphenoidal resection of a pituitary adenoma. The sinonasal lesion was an incidental finding during this intervention and was removed from the posterior part of the nasal septum. Case 2 presented with unilateral nasal obstruction and intermittent epistaxis for 2 months' duration. Imaging revealed a large mass occupying the ethmoid sinuses, nasal cavity, and most of the maxillary sinus (Figs. 1A-C) . This patient underwent a combined endoscopic and Caldwell resection. Case 3 presented with unilateral nasal obstruction and discharge for 12 months' duration, and underwent endoscopic resection, which was nonradical. Two subsequent recurrences were nonradically excised, and adjuvant radiotherapy was administered at the second recurrence. All 3 patients are currently alive without evidence of disease.
DISCUSSION
In the head and neck region, chromosomal translocations resulting in the formation of fusion oncogenes have been identified as defining, pathognomonic events in numerous types of salivary gland carcinomas, whereas translocation-associated carcinomas in the sinonasal tract are found exclusively in the salivary-type adenocarcinoma category. 2, 25 This study draws attention to a form of lowgrade SNAC morphologically distinct from any type of salivary gland carcinoma, harboring the genetic hallmarks of SC of the salivary gland (Fig. 3B) . 15 The morphology as well as immunophenotype (ie, DOG1 positivity, absence of GATA3 and mammaglobin, and only patchy S-100 expression) delineates its clear separation from SC, despite this genetic overlap. We propose the designation ETV6-rearranged low-grade SNAC for this novel type of translocation-associated carcinoma unique to the sinonasal tract. As known from SC, the classic gene fusion between exon 5 of ETV6 and exon 15 of NTRK3 is not always present, but alternative chromosomal breakpoints in these genes can result in atypical fusions (Fig. 3B) . 18 In a minority of SC, ETV6 is fused to a yet unknown non-NTRK3 partner gene, termed the ETV6-X genotype. 18 In this study, our case 3 is the equivalent of this phenomenon in ETV6-rearranged low-grade SNAC, and the genetic driver in this case, akin to ETV6-X in SC, is unknown but may be found among the more than 90 different genes described as recurrently ETV6 fusion partner genes. 35 Only very few ETV6-X SCs have been reported, leaving the significance of this alternative genetic mechanism unclear. Yet another peculiarity found in this very limited number of ETV6-rearranged low-grade SNACs is the selective amplification of the centromeric 3 0 region of the NTRK3 gene in case 1, encoding the NTRK3 kinase domain responsible for the malignant phenotype (Figs. 2C, 3B) . To the best of our knowledge, this finding has not been described in SC. However, this feature did not seem to imply a more aggressive clinical course, as this case was an incidental finding without any sign of more aggressive behavior clinically or histologically.
An increasing number of distinct types of sinonasal carcinomas have been recognized through recent years, which can, although the underlying biology is complex, be reliably identified by the application of a few immunohistochemical stains selected on the basis of morphology (eg, NUT carcinoma, SMARCB1-deficient sinonasal carcinoma, renal cell-like adenocarcinoma, and human papillomavirus-related carcinoma with adenoid cystic-like features). [36] [37] [38] [39] In the case of ETV6-rearranged low-grade SNAC, the distinct morphology and immunohistochemical expression of DOG1 and GCDFP-15 seem to separate these from nonrearranged low-grade SNACs, but further studies are needed to confirm this. However, one pitfall in identifying ETV6-rearranged low-grade SNAC highlighted by our findings is the identification of true SCs occurring in the sinonasal tract (Tables 2 and 3 ).
The present paper highlights that at least a subset of SNACs differentiate similar to the submucosal seromucous glands. Namely, we found immunoreactivity for DOG1 and SOX10 and consistent involvement of the ETV6 gene, which in the head and neck is found exclusively in a type of salivary gland carcinoma (ie, SC) and not in tumors of surface origin at any site. 15, 40, 41 Tubular low-grade SNACs (the predominant growth pattern in ETV6-rearranged low-grade SNAC) were found in the study by Jo et al 6 to be associated with REAH in one-third of cases. As REAH is of surface epithelial origin, this finding is intriguing, and we sought to explore the genetic relationship between these lesions further. 42 We found ETV6 to be intact in REAHs, not supportive of an association between REAH and ETV6-rearranged low-grade SNAC. Although the immunophenotype of the lowgrade SNACs in the Jo and colleagues study was not further explored, Purgina et al 12 meticulously described a striking overlap in DOG1 and SOX10 expression between seromucinous hamartomas and a subset of low-grade SNAC, of which at least some cases were highly similar to the ETV6-rearranged low-grade SNAC described here. As seromucinous hamartoma, in contrast to REAH, is believed to be of seromucinous gland origin, this possible association deserves further investigation. 14 In conclusion, we present 3 cases of a morphologically and immunohistochemically distinct type of lowgrade SNAC with genetic similarity to SC of salivary gland, provisionally termed ETV6-rearranged low-grade SNAC. The availability of the immunohistochemical panel aiding in the diagnosis, in particular DOG1 and GCDFP-15 expression, along with the widespread use of ETV6 break-apart FISH in head and neck pathology paves the way for the identification of additional cases and meaningful correlation with clinical parameters. 1 and 3 (A, B) . The cysts were lined by cuboidal-to-cylindrical tumor cells with focal apocrine features (A, inset). 
